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The first adult-repopulating hematopoietic stem cells
(HSCs) emerge in the aorta-gonads-mesonephros
(AGM) region of the embryo. We have recently iden-
tified the transcription factor Gata3 as being upregu-
lated in this tissue specifically at the time of HSC
emergence. We now demonstrate that the produc-
tion of functional and phenotypic HSCs in the AGM
is impaired in the absence of Gata3. Furthermore,
we show that this effect on HSC generation is
secondary to the role of Gata3 in the production of
catecholamines, the mediators of the sympathetic
nervous system (SNS), thus making these molecules
key components of the AGM HSC niche. These find-
ings demonstrate that the recently described func-
tional interplay between the hematopoietic system
and the SNS extends to the earliest stages of their
codevelopment and highlight the fact that HSC
development needs to be viewed in the context of
the development of other organs.
INTRODUCTION
The emergence of adult-repopulating hematopoietic stem cells
(HSCs) initiates in the mouse embryo at embryonic day (E) 10.5
in an intraembryonic region that comprises the developing circu-
latory, reproductive, and excretory systems and has therefore
been termed the aorta-gonads-mesonephros (AGM) region
(Medvinsky and Dzierzak, 1996; Medvinsky et al., 1993; Mu¨ller
et al., 1994). This tissue is of a highly dynamic and transient
nature and only contains HSCs between E10.5 and E12.5, at
which point the fetal liver has established itself as the main
hematopoietic organ for the remainder of fetal development
(Kumaravelu et al., 2002). The origin of HSCs within the AGM
and the process of their generation have been the matter of
intense debate over the past decade; however, recent findings
have started to shed some light on these issues (for a recent
review, see Ottersbach et al., 2010). Originally, two seemingly
conflicting theories were put forward of either an endothelial554 Cell Stem Cell 11, 554–566, October 5, 2012 ª2012 Elsevier Inc.(Jaffredo et al., 1998, 2000) or a subaortic mesenchymal
(Bertrand et al., 2005) precursor cell for HSCs. Recent lineage
tracing experiments have reported the existence of hemogenic
endothelial cells in the mouse AGM that contribute to the
production of definitive blood both in the embryo and in the adult
(Chen et al., 2009; Zovein et al., 2008). However, there is also
evidence for the existence of an early subaortic mesenchymal
population that expresses smooth muscle cell markers and
that contributes to blood formation via an endothelial interme-
diate, thus providing a possible link between the two original
hypotheses (Rybtsov et al., 2011; Zovein et al., 2008). There is
also recent evidence that the yolk sac may contribute to HSC
precursors (Samokhvalov et al., 2007; Tanaka et al., 2012).
Progress has also been made in defining the components that
make up the hematopoietic regulatory microenvironment of the
AGM. Cells with characteristics of mesenchymal stromal cells,
which are known to be crucial elements in the adult HSC niche,
have been identified in the AGM (Mendes et al., 2005), and
AGM-derived stromal cell lines have proven to be a powerful
tool for the identification of environmental HSC regulators
(Durand et al., 2007; Ohneda et al., 2000; Oostendorp et al.,
2005; Renstro¨m et al., 2009). Furthermore, it was demonstrated
that tissues ventral to the AGM have an enhancing effect on HSC
emergence, while tissues on the dorsal side decrease HSC
production (Peeters et al., 2009; Taoudi and Medvinsky, 2007),
pointing to the important concept that HSC generation in the
AGM occurs in the wider context of the tissues that develop
around it.
We have recently carried out microarray expression analyses
of the AGM region with the aim of identifying HSC regulators
(Mascarenhas et al., 2009). In addition to known hematopoiesis-
associated genes, upregulation of genes known to be involved
in the development of tissues surrounding the aorta was also
noted, again suggesting that HSC emergence is functionally
linked to other developmental processes that proceed in the
vicinity of the dorsal aorta.
Among the upregulated genes was the transcription factor
Gata3, which is involved in the development of a number of
cell and tissue types, including skin, mammary gland, kidney,
sympathetic nervous system (SNS), and adipocytes (Asselin-
Labat et al., 2007; Grote et al., 2006; Kaufman et al., 2003;
Kouros-Mehr et al., 2006; Kurek et al., 2007; Pandolfi et al.,
Table 1. Effect of Gata3 Deletion on AGM HSC Numbers
Genotype Number of Mice Repopulated/Total Transplanted Mice Reconstituted (%) Chimerism (%)
Direct transplantationa Gata3+/+ 7/12 (58) 11–89
Gata3+/ 4/23 (17) 26–85
Gata3/ 1/7 (14) 10
After explantb Gata3+/+ 4/9 (44) 11–100
Gata3+/ 10/17 (59) 11–75
Gata3/ 1/7 (14) 28
The percentage of chimerism was determined by semiquantitative PCR. See also Figure S1.
aAGMs from Gata3+/+, Gata3+/, or Gata3/ E11 embryos were dissociated with collagenase treatment and directly transplanted as one tissue per
recipient (1 embryo equivalent [ee]) into irradiated adult recipients.
bAGMs fromGata3+/+,Gata3+/, orGata3/E11 embryoswere cultured as explants for 3 days before being dissociated and transplanted (as 1 ee) into
irradiated adult recipients.
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has been linked to the development of T cells (Ting et al., 1996)
and thymic natural killer cells (Vosshenrich et al., 2006). More-
over, Gata3 expression was reported in embryonic and adult
HSCs (Benveniste et al., 2010; Bertrand et al., 2005; Kent
et al., 2009) and the knockout embryos were shown to have
defective fetal liver hematopoiesis (Pandolfi et al., 1995). More
recently, two groups have confirmed Gata3 expression in adult
HSCs and have examined a possible role for Gata3 in adult
HSC function. While Buza-Vidas et al. have found no effect of
a panhematopoietic Gata3 deletion on the ability of HSCs to
long-term repopulate and self-renew (Buza-Vidas et al., 2011),
Ku et al., using a complete Gata3 null line and an adult hemato-
poiesis- and bone-marrow-niche-specific Gata3 knockout, re-
ported that Gata3 is required for adult HSC maintenance via
regulation of cell cycle entry (Ku et al., 2012).
Considering the reported role of Gata3 in the hematopoietic
system and its importance in the development of various other
tissues, we hypothesized that it may also be involved in the
generation of the first HSCs, especially since we previously
found Gata3 to be upregulated in the E11 AGM. We therefore
analyzed Gata3-deficient embryos and detected a marked
reduction in functional and phenotypic HSCs in the AGM.
Surprisingly, this was largely independent of a cell-intrinsic role
of Gata3, but was secondary to its function in the developing
SNS, thus providing an example of amolecular defect in an adja-
cent tissue having a profound impact on HSC production in the
dorsal aorta.
RESULTS
Gata3 Deletion Causes a Reduction in Hematopoietic
Stem and Progenitor Cells in E11.5 and E10.5 AGMs
To determine if Gata3 plays a role in the emergence of HSCs,
we analyzed the repopulation activity of AGMs from Gata3
knockout embryos in transplantation assays. When E11–11.5
AGMs were dissected from Gata3+/+, Gata3+/, and Gata3/
embryos anddirectly transplanted into adult recipients, amarked
reduction in the repopulation ability of Gata3+/ and Gata3/
AGMs was observed (Table 1 and Figure S1 available online).
While almost 60%of mice transplanted with wild-type AGMcells
showed more than 10% donor contribution to their peripheral
blood, less than 20% of mice were repopulated by Gata3+/Ceand Gata3/ AGM-derived HSCs. In fact, only one mouse out
of seven injected withGata3/ AGM cells had detectable levels
of donor contribution, and these did not exceed 10%, even after
more than 4 months. Placing E11 AGMs into whole-organ
explant culture for 3 days prior to transplantation allowed HSC
activity in heterozygous AGMs to recover to that of wild-type
levels, while the defect remained in Gata3 null AGMs (Table 1
and Figure S1). These results suggest that reduced levels of
Gata3 impair the emergence and/or expansion of HSCs in
the AGM.
HSC production in the AGM initiates at E10.5 (Mu¨ller et al.,
1994). However, numbers of HSCs are limited at that time point,
making an accurate comparison of HSCs in E10.5 wild-type or
Gata3-deficient AGMs by direct transplantations impossible.
We therefore analyzed the number of immature late-developing
colony-forming units-spleen (CFU-S11) progenitors (Figure S1).
While all of the wild-type and heterozygous E10.5 AGMs con-
tained CFU-S11 cells, only three out of eight injected Gata3
/
AGMs produced spleen colonies in the recipients. Moreover, in
those three AGMs, the frequency of CFU-S11 cells was less
than half of that observed in Gata3+/+ and Gata3+/ E10.5
AGMs. This implies that Gata3 plays a role in the production of
hematopoietic progenitors and the first HSCs that emerge in
the midgestation embryo.
Intra-Aortic Clusters and Phenotypic HSCs Are Reduced
in E11 Gata3–/– Aortae
To analyze HSCs phenotypically, we crossed the Gata3
knockout line with the Ly-6A GFP transgenic mouse line, which
expresses the green fluorescent protein (GFP) under the regula-
tory elements of the HSCmarker Sca1 and which was previously
shown to mark all HSCs in the AGM (de Bruijn et al., 2002).
Sections were prepared from Gata3+/+ GFP+ and Gata3/
GFP+ embryos along the whole length of the AGM region, and
the number of GFP+ cells within the endothelial layer of the
dorsal aorta was counted on every tenth section. This method
was previously used to highlight a reduction in phenotypic
HSCs in Gata2+/ embryos (Ling et al., 2004). In three indepen-
dent experiments, we found a 2- to 3-fold reduction in the
percentage of Ly-6A GFP+ cells within the endothelium of
E10.5 and E11.5 Gata3/ aortae (Figures 1A–1C). The total
number of endothelial cells was not affected by the Gata3 defi-
ciency (data not shown). Representative sections are shown inll Stem Cell 11, 554–566, October 5, 2012 ª2012 Elsevier Inc. 555
Figure 1. Phenotypic HSCs Are Reduced in Gata3-Deficient Embryos
Sections were prepared from E10.5–E11.5Gata3+/+ Ly-6A GFP+ andGata3/Ly-6A GFP+ embryos that had been staged according to their somite pairs (E10.5)
or according to the pigmentation around their eyes (E11). Sections were costained for CD34 and the number of GFP+ cells within the total endothelial cells were
counted on confocal images of every tenth section. Representative sections ofGata3+/+ Ly-6AGFP+ andGata3/ Ly-6AGFP+ embryos are shown in (A) and (B),
respectively. GFP, green; CD34, red/Cy5; ventral, down. A summary of the results from three independent experiments is shown in (C). SP, somite pairs; s, stage.
Sections of E11Gata3+/+ (D) andGata3/ (E) embryos were stained with a riboprobe forGfi1. Ventral, down, 103/0.25 objective. Levels ofGfi1were determined
in subdissected E11Gata3+/+ andGata3/ aorta-mesenchyme by quantitative RT-PCR (F). Error bars represent SD. (G) Quantitative RT-PCRwas performed on
cDNA prepared from ventral halves of aorta-mesenchymes from E11Gata3+/+ (n = 3),Gata3+/ (n = 7), andGata/ (n = 3) embryos for the named genes and was
normalized to Actb and Tbp. *p < 0.05, **p < 0.01; error bars represent the SEM of the normalized relative expressions.
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results in fewer phenotypic HSCs and possibly also a reduction
in hemogenic endothelial cells, which are also thought to express
the Ly-6A GFP transgene (de Bruijn et al., 2002).
We also examined the presence and morphology of intra-
aortic clusters, which are believed to be signs of HSC emergence
in the dorsal aorta. Sections from E11 Gata3+/+ and Gata3/
embryos were stained for the expression of the transcription
factor growth factor independence 1 (Gfi1), which is known to556 Cell Stem Cell 11, 554–566, October 5, 2012 ª2012 Elsevier Inc.be expressed in adult HSCs and to be required for their mainte-
nance (Hock et al., 2004; Khandanpour et al., 2010). Figure 1D
shows that Gfi1 is strongly and specifically expressed in the
intra-aortic clusters of E11 wild-type embryos, as reported previ-
ously (Wilson et al., 2010). This specific expression pattern of
Gfi1 was then used to demonstrate that the number and the
size of intra-aortic clusters is reduced in Gata3/ embryos
(Figures 1D and 1E), which was also shown quantitatively (Fig-
ure 1F). We looked for changes in expression of other known
Figure 2. Gata3 Is Not Expressed in Hematopoietic Cells in the E11.5 AGM Region
(A) Gata3+/+ (top panels) and Gata3lz/+ (bottom panels) E11.5 AGM cells were loaded with the fluorescent b-galactosidase substrate FDG and analyzed for
coexpression of CD41, CD45, ckit, and CD31 (FL2).
(B) Mesenchymal (MC), endothelial (EC), and hematopoietic stem cell (HSC) populations were sorted from E11.5 wild-type aorta-mesenchymes using the
indicated marker combinations and the levels of Gata3 transcripts (normalized to Actb and Tbp) determined by quantitative RT-PCR.
Cell Stem Cell
Catecholamines and Blood Stem Cell DevelopmentHSC markers by quantitative RT-PCR analysis of ventral halves
of subdissected aorta-mesenchyme tissue. While Bmp4 and
C-myb levels were not affected by the absence of Gata3, there
was a significant reduction in Runx1 and Gata2 expression
(Figure 1G). These results validate that phenotypic HSCs, as
detected by the expression of Ly-6A GFP, are reduced in
AGMs deficient for Gata3 and that their production may be dis-
rupted, as evidenced by the diminished number of hemogenic
endothelial cells and intra-aortic clusters.
Gata3 Is Expressed in Various Cell Types in the E10
and E11.5 AGM
To understand the mechanism by which Gata3 regulates HSC
production in the AGM, its expression in specific cell types
was determined using a Gata3-LacZ knockin mouse line (van
Doorninck et al., 1999). Flow cytometry analysis of FDG-loaded
cells from E11.5 Gata3+/lz AGMs revealed Gata3 expression in
some ckit+ and some CD31+ cells (Figure 2A). However, when
compared with the background control (no antibody), there
does not seem to be any overlap between Gata3-expressingCecells and CD41+ or CD45+ cells, suggesting that Gata3 is not
expressed in hematopoietic cells in the AGM. Furthermore,
isolating cell populations enriched for HSCs, endothelial cells,
and mesenchymal cells from E11.5 wild-type subdissected
aorta-mesenchymes by flow sorting using a combination of
well-established markers (North et al., 2002; Robin et al., 2011;
Sa´nchez et al., 1996) and analyzing these by quantitative RT-
PCR showed that there is little to no Gata3 expression in pheno-
typic HSCs (Figure 2B).
To further investigate if Gata3 is expressed in HSCs, Gata3-
LacZ+ and LacZ cells were tested for repopulation activity in
transplantation assays. In the first set of experiments, LacZ+
and LacZ cells were sorted from freshly dissected E11.5
Gata3+/lz AGMs (the urogenital ridges were removed prior to
sorting to eliminate LacZ+ mesonephric duct cells) and directly
injected into recipients. However, none of the 14 mice injected
with LacZ+ cells showed any signs of repopulation, while
only 1 out of 13 recipients was robustly repopulated with
Gata3-LacZ cells (Table 2). This low level of HSC activity in
both cell populations is most likely due to the heterozygousll Stem Cell 11, 554–566, October 5, 2012 ª2012 Elsevier Inc. 557
Table 2. HSC Activity in Sorted AGM Cell Populations from E11 Gata3+/lz Embryos
Cell Population Cell Dose (Embryo Equivalent)
Number of Mice Repopulated/Total
Transplanted Chimerism (Percent)
Direct transplantationa Gata3-LacZ+ 1–5 0/13 0
Gata3-LacZ 1–4 1/14c 38
After explant with IL3b Gata3-LacZ+ 1–2 0/4 0
Gata3-LacZ 1–2 4/4 46–100
The percentage of chimerism was determined by semiquantitative PCR.
aAGMs were dissected from Gata3+/lz E11 embryos, the urogenital ridges were removed, and the cells were dissociated with collagenase treatment,
stained with FDG, sorted into LacZ+ and LacZ populations, and directly transplanted into irradiated adult recipients.
bAGMs were dissected from Gata3+/lz E11 embryos and cultured as explants in the presence of 100 ng/ml IL3. After 3–4 days, they were dissociated
with collagenase treatment, stained with FDG, sorted into LacZ+ and LacZ populations, and transplanted into irradiated adult recipients.
cWe detected the donor marker in a second recipient. However, since the contribution was below 10%, it was counted as negative.
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reduced repopulation activity in direct transplantation assays
with total AGM cells fromGata3+/ embryos (Table 1). We there-
fore cultured E11.5 Gata3+/lz AGMs as whole-organ explants for
3 days in the presence of Interleukin 3, which has previously
been demonstrated to expand AGM HSCs (Robin et al., 2006).
At the end of the culture period, LacZ+ and LacZ cells were
sorted and analyzed in transplantation assays. The results in
Table 2 clearly show that all of the long-term repopulating activity
resides within the Gata3-LacZ fraction, with all of the recipients
that received LacZ cells displaying high levels of donor chime-
rism, while none of the recipients of LacZ+ cells showed any
signs of repopulation.
To analyze the spatial distribution of Gata3-expressing cells
within the AGM, we prepared sections from X-gal-stained
Gata3+/lz embryos. As previously described, Gata3 expression
was detected in the mesonephric ducts (Figure 3A), which is in
line with its reported function in the developing kidney (Grote
et al., 2006). Gata3 expression was also observed in sympathoa-
drenal progenitors, which form the developing adrenal gland and
sympathetic ganglia of the SNS (Huber, 2006), the development
of which is known to be Gata3 dependent (Lim et al., 2000;
Moriguchi et al., 2006; Tsarovina et al., 2004). Upon closer
inspection of the aortic region, we also saw additional Gata3
staining in subendothelial cells underneath the lateral and ventral
aspect of the dorsal aorta (Figures 3B and 3C). This pattern over-
laps with the subaortic patches that have previously been
described (Bertrand et al., 2005; Manaia et al., 2000) and may
also coincide with the compartment where other known HSC
regulators, such as Bmp4 and Runx1, are expressed (Durand
et al., 2007; North et al., 1999). This staining was particularly
prominent underneath intra-aortic clusters (arrow in Figure 3B).
Importantly, we did not detect any Gata3 expression in the clus-
ters themselves or in any other hematopoietic cells, as sug-
gested from the flow cytometry results in Figure 2. Some isolated
endothelial cells were found to be Gata3-LacZ+ (arrowheads in
Figure 3C), which again confirms our flow cytometry analysis
results that showed some overlap between Gata3-LacZ and
CD31 expression (Figure 2A). The observed Gata3 expression
pattern was verified by immunohistochemistry, which confirmed
Gata3 expression in the SNS (as evidenced by the overlap with
the sympathoadrenal marker tyrosine hydroxylase, Th, Fig-
ure 3H) with additional staining observed in the subaortic mesen-
chyme (arrows in Figure 3H), especially underneath intra-aortic558 Cell Stem Cell 11, 554–566, October 5, 2012 ª2012 Elsevier Inc.clusters (arrow in Figure 3G), and in endothelial cells (arrowheads
in Figure 3G).
We also extended our analysis to E10 embryos, which again
showed subendothelial Gata3 expression, albeit in fewer cells,
in the vicinity of intra-aortic clusters (Figures 3D and 3F). At
this stage, sympathoadrenal cells are restricted to two lateral
patches on either side of the dorsal aorta (Figure 3E). Taken
together, these results suggest that Gata3 may regulate AGM
HSCs in a non-cell-autonomous fashion.
Gata3 Regulates HSC Numbers via the Production of
Catecholamines
As mentioned above, Gata3 is essential for the formation of the
SNS (Lim et al., 2000; Moriguchi et al., 2006; Tsarovina et al.,
2004, 2010). We confirmed this by comparing the expression
pattern of three genes that are active in cells of the developing
SNS, in sections of wild-type and Gata3/ embryos. These
genes included Th, an enzyme required for the biosynthesis of
catecholamines, the mediators of the SNS; the transcription
factor Gata2, which is known to lie downstream of Gata3 in the
development of the SNS (Tsarovina et al., 2004); and the tran-
scription factor Hand1 (Cserjesi et al., 1995; Morikawa and
Cserjesi, 2004). Th and Hand1 expression are restricted to sym-
pathoadrenal cells in wild-type AGMs and are completely absent
in Gata3/ AGMs (Figure 4A). In addition to its expression in
sympathoadrenal cells,Gata2 is also expressed in the urogenital
ridges in the tissue surrounding the mesonephric ducts, in the
coelomic epithelium, and in the endothelium of the dorsal aorta
(Figures 4A and S2A). Its expression in the SNS is completely
abrogated in Gata3/ embryos. Interestingly, Gata2 is also
reduced around the mesonephric ducts, suggesting that it may
also act downstream of Gata3 in kidney development. There
were also fewer Gata2-expressing cells in the endothelium of
Gata3/ embryos as well as fewer Gata2+ intra-aortic clusters,
thus providing further evidence for a disruption in HSC produc-
tion in the AGM (Figure S2A).
The dual role of Gata3 in the developing hematopoietic system
and SNS is intriguing in the light of recent reports that have
demonstrated a role for the SNS in adult HSCmobilization, prolif-
eration, and repopulation (Katayama et al., 2006; Me´ndez-Ferrer
et al., 2008; Spiegel et al., 2007). It led us to hypothesize that
such a functional link between these two systems might also
exist during their development and that the function of Gata3
in the emergence of HSCs in the AGM may be secondary to its
Figure 3. Gata3 Is Expressed in a Number of
Different Cell Types in the AGM
E11.5 (A–C) and E10 (D–F)Gata3lz/+ embryos were
stained with X-gal (blue) and cryosections were
counterstained with Neutral Red. Ventral, down.
Objectives were 103/0.25 (A), 203/0.45 (B, C,
and E), 403/0.65 (D), or 1003/1.4 (F). Arrows in (B)
and (D) point to intra-aortic clusters; arrowheads
in (C) highlight Gata3-expressing endothelial cells.
(F) A close-up of the cluster in (D). (G and H) E11.5
wild-type sections were costained for Gata3 (red/
Cy5) and CD34 (green/FITC) (G) or Th (green/Alexa
488) (H) and confocal images were obtained.
Arrows in (G) and (H) point to Gata3 staining in
subaortic mesenchymal cells, and arrowheads in
(G) point to Gata3+ endothelial cells. ag, adrenal
anlage; ao, dorsal aorta; fl, fetal liver; gt, gonadal
tissue; md, mesonephric duct; sg, sympathetic
ganglia; Th, tyrosine hydroxylase.
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a deficiency in the production of catecholamines from sympa-
thoadrenal cells (Lim et al., 2000; Moriguchi et al., 2006). This
early lethality can be delayed with a pharmacological rescue
protocol in which a- and b-adrenergic agonists are supplied to
the embryos via the drinking water of the pregnant dams (Lim
et al., 2000; Pattyn et al., 2000). If, in analogy with their role in
the adult hematopoietic system, catecholamines also regulate
HSCs in the AGM, supplying the Gata3-deficient embryos with
an external source of these mediators should also restore AGM
hematopoiesis. We therefore started the rescue protocol at
E8.5, obtained AGMs from these embryos at E11.5, and trans-
planted them directly. This led to a marked recovery of HSC
activity in both heterozygous and Gata3 null AGMs with the per-
centage of repopulated recipients having more than doubled
(compare direct transplantation results in Table 1with Figure 4B).
The reconstitution levels obtained in the recipients repopulated
with Gata3/ AGMs were also markedly improved (Figure 4B
and Figure S2B). This suggests that the HSC defect observed
in E11 Gata3-deficient AGMs is indeed secondary to the role
Gata3 plays in the developing SNS. To provide further evidence
we also determined HSC activity in Th knockout mice, in which
the only deficiency is the absence of catecholamine production.
Indeed, there was a similar reduction in repopulation activity
in Th/ and Gata3/ AGMs (compare Figure 4C with Table 1
and Figure S1 with Figure S2C). Furthermore, we were also
able to produce a dramatic reduction in HSCs by adding a Th
inhibitor to AGM explant cultures (Figure 4D). Flow cytometry
analysis showed that thiswasdue to adecrease in theproduction
of ckit+CD45+cells because therewasno increase in the number
of apoptotic cells within that population (Figures 4E and 4F).
The Effect of Catecholamines on Developing HSCs Is
Independent of Blood Flow
Based on the phenotype of embryos deficient for Th or dopa-
mine b-hydroxylase, two enzymes involved in the synthesis ofCell Stem Cell 11, 554–566catecholamines, it was suggested that
catecholamines are necessary for proper
cardiovascular function and the ability tomaintain a sufficient heart rate (Thomas et al., 1995; Zhou
et al., 1995). Interestingly, it was recently demonstrated that
a heartbeat and the sheer stress induced by a robust blood
flow are needed for the generation of HSCs in the dorsal aorta
via the production of nitric oxide (Adamo et al., 2009; North
et al., 2009). An interpretation of our results may therefore
be that the absence of catecholamines in the Gata3-deficient
embryos has a negative impact on blood flow and reduces the
sheer stress that hemogenic endothelial cells are exposed to in
the aorta, thus leading to defective HSC production. To deter-
mine whether the absence of Gata3 leads to a reduction in sheer
stress and diminished nitric oxide production, we analyzed the
expression of the nitric-oxide-synthesizing enzyme Nos3
because it is known to be required for HSC production in the
AGM (North et al., 2009). Figures 5A and 5B clearly show that
Nos3 levels in the floor of the dorsal aorta are not reduced in
the absence of Gata3, implying that Gata3 deficiency does not
cause a reduction in the blood flow through the aorta.
To further demonstrate that the effect of catecholamines on
HSC production in the AGM is indeed independent of the
presence of a robust blood flow, we investigated whether cate-
cholamines retained their ability to rescue the HSC deficiency in
Gata3/ embryos in an in vitro AGMexplant culture system (Fig-
ure 5C). E11 AGMs were dissected fromGata3+/+,Gata3+/, and
Gata3/ embryos, cultured in the presence of catecholamine
derivatives at concentrations previously shown to be effective
in vitro (Me´ndez-Ferrer et al., 2008; Toda et al., 2007; Wei
et al., 2007) and transplanted into irradiated recipients. The
results in Figure 5D demonstrate that exposure of AGMs to
catecholamines in vitro can indeed restore HSC levels in Gata3
null AGMs, with the number of repopulated mice equaling the
number repopulated with wild-type AGMs in the absence of
catecholamines (compare Figure 5D with Table 1). The effect
of catecholamines in vitro seems to be even more pronounced
than when they were administered in vivo (compare Figure 5D
with Figure 4B). In fact, even Gata3+/+ and Gata3+/ AGMs, October 5, 2012 ª2012 Elsevier Inc. 559
Figure 4. Gata3 Regulation of AGM HSCs Is Secondary to Its Role in the Sympathetic Nervous System
(A) In situ hybridization with riboprobes for Th, Gata2, and Hand1 on Gata3+/+ and Gata3/ E11.5 embryo sections.
(B) Summary of repopulation analysis of recipients injected with uncultured E11/11.5 AGM cells (1 ee) from Gata3+/+, Gata3+/, and Gata3/ embryos that had
received catecholamine derivatives in vivo through the drinking water from E8.5. See also Figure S2.
(C) Summary of repopulation analysis of recipients injected with uncultured E11/11.5 AGM cells (1 ee) from Th+/+, Th+/, and Th/ embryos. See also Figure S2.
(D) Percentage of recipients repopulated with wild-type E11.5 AGMs that had been cultured in the presence or absence of a Th inhibitor. The number of
repopulated/total recipients is indicated above each bar.
(E and F) Flow cytometry analysis of ckit and CD45 expression on cells from E11.5 wild-type AGMs cultured in the absence (E) or presence (F) of a Th inhibitor. The
percentage of apoptotic cells within the ckit+CD45+ population is shown.
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repopulation potential (compare Figure 5D with Figure 4B and
Table 1). This increase in repopulation potential in in-vitro-
treated AGMs was also reflected in the donor chimerism of indi-
vidual (repopulated) mice (compare Figure S3 with Figure S1).
This shift toward higher repopulation levels in individual mice
was already to some extent observed with recipients that had
been injected with AGMs treated with catecholamines in vivo
(Figure S2B).
Adrenergic Receptors Are Present on Nascent HSCs
Both the b2- (Adrb2) and the b3- (Adrb3) adrenergic receptors
have been proposed to relay the effect of the SNS on adult
HSCs. The b2-adrenergic receptor was shown to be expressed
on the surface of HSCs (Spiegel et al., 2007), thus allowing the
SNS to act directly on stem cells, while the b3-adrenergic
receptor was reported to be expressed on bone marrow stromal560 Cell Stem Cell 11, 554–566, October 5, 2012 ª2012 Elsevier Inc.cells (Me´ndez-Ferrer et al., 2008), implying that SNS-mediated
HSC mobilization occurred indirectly via the niche. We analyzed
the expression of these two receptors in sorted populations
of mesenchymal, endothelial, and hematopoietic stem cells
from the E11.5 aorta-mesenchyme region by quantitative RT-
PCR (Figure 5E). Since the rescue protocol also includes an
a1-adrenergic receptor agonist and the catecholamines adren-
aline and noradrenaline can also bind to the a1-adrenergic
receptor (Adra1d), we included this receptor in the same
expression analysis. Only the b2-adrenergic receptor displayed
high levels of expression in HSCs (Figure 5E). Flow cytometry
analysis confirmed that it is expressed on a subset of CD34+
(75%) and CD45+ (23%) cells (Figure 5F). We therefore further
analyzed the localization of the b2-adrenergic receptor by
immunohistochemistry on E11.5 embryo sections and detected
it on cells of the neural tube, the dorsal root ganglia, the
myotome, the fetal liver, and the dorsal aorta (Figure 5G).
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on numerous blood cells in the circulation, on some endothelial
cells (arrow in Figure 5H), and on more rounded cells in the
ventral endothelium (arrow in Figure 5I). This expression pattern
suggests that catecholamines may be acting directly on HSCs
or their precursors and also on more mature blood cells in the
circulation.
DISCUSSION
We have demonstrated that a deficiency in Gata3 leads to
a marked reduction in the production of HSCs in the AGM.
Our data suggest that Gata3 deficiency disrupts HSC develop-
ment through its role in directing expression of Th and hence
catecholamine production in cells of the SNS, thus making
the SNS an important component of the developing HSC
microenvironment.
The HSC defects in Gata3-deficient embryos are dose depen-
dent. In direct transplantations, Gata3 haploinsufficient AGM
cells show a reduction in HSC activity that is similar to what we
observed with homozygous null AGM cells. Interestingly, when
haploinsufficient AGMs were cultured as whole organ explants
for 3 days prior to transplantation, HSC activity recovered to
wild-type levels. This could be explained by the possibility that,
unlike in Gata3/ embryos, functional HSCs are present in
Gata3+/ E11 AGMs, albeit in reduced numbers, and these
HSCs have the capacity to expand during the culture step. Addi-
tionally, the explant culture medium may contain traces of cate-
cholamines that are enough to rescue the defect in the Gata3+/
AGMs, but not in theGata3/ AGMs. To test this, we performed
an ELISA for adrenaline and noradrenaline on the explant culture
medium and indeed found traces of these two catecholamines
(5 nM adrenaline and 1 nM noradrenaline). CFU-S numbers in
the E10.5 AGM seem to be less sensitive to the dose of Gata3
because their numbers are normal in Gata3+/ embryos. This
may hint at a different requirement for Gata3 in HSCs compared
with that in CFU-S.
Despite reports of Gata3 expression in immature Rag1gc/-
repopulating cells, in primitive HSCs in human cord blood, and in
adult HSCs (Benveniste et al., 2010; Bertrand et al., 2005; Kent
et al., 2009; Panepucci et al., 2009, 2010), we were unable to
detect robust levels of Gata3 expression in hematopoietic cells
or phenotypic HSCs sorted from the AGM. Furthermore, all of
the repopulating activity in the E11.5 AGM was found in the
Gata3-LacZ cell fraction. While we cannot rule out that there
is some Gata3 expression in a rare subset of AGM HSCs, in
which it might perform a function similar to what has been
described for adult HSCs (Ku et al., 2012), these results may
also suggest that Gata3 plays a non-cell-autonomous role
during the emergence of HSCs during development. This micro-
environmental role of Gata3 in HSC generation would also
explain why Gata3/ ESCs were able to contribute to all hema-
topoietic lineages, apart from T cells, in blastocyst chimeras
when a wild-type microenvironment is provided (Ting et al.,
1996).
To determine the component of the HSC regulatory microen-
vironment that is affected by the Gata3 deletion, we concen-
trated on the SNS because Gata3 has a well-documented role
in sympathoadrenal lineage development (Lim et al., 2000;CeMoriguchi et al., 2006; Tsarovina et al., 2004, 2010). Intriguingly,
a rescue of the SNS defect in Gata3-deficient embryos by the ex-
ternal supply of catecholamines also resulted in the restoration
of HSC activity in E11 Gata3/ AGMs. Furthermore, catechol-
amines were also able to rescue the HSC defect when added
to dissected AGMs in ex vivo explant cultures. In addition, the
HSC defect was recapitulated in another mouse model for cate-
cholamine deficiency, in which Th was deleted, and addition of
a Th inhibitor to wild-type AGM explant cultures had a profound
negative effect on HSC numbers.
Previously, an influence of the SNS on HSC behavior in the
adult system has been documented. It was shown that catechol-
amines regulate HSC proliferation and migration by acting either
on the niche or onHSCs directly (Katayama et al., 2006;Me´ndez-
Ferrer et al., 2008; Spiegel et al., 2007). Both the b2- and the
b3-adrenergic receptor were shown to be involved in mediating
catecholamine signaling in this context. Our results now extend
this functional association between the SNS and the definitive
hematopoietic system to the time point when they both develop
in close proximity to each other in the AGM region. We found
robust expression of the b2-adrenergic receptor in the AGM
and localized it to HSCs, other hematopoietic cells inside the
lumen of the aorta, and endothelial cells on the ventral side of
the dorsal aorta. Some of these endothelial cells showed
a more rounded appearance, suggesting that these may be
hemogenic and/or nascent HSCs and hence implying the action
of catecholamines directly on emerging HSCs or their direct
precursors. Adrenergic receptor expression was also found on
some AGM-derived stromal cell lines with supportive capacity
(data not shown), raising the possibility that catecholamines
may additionally act on cells of the developing HSC niche.
However, adding catecholamines to cocultures of AGM HSCs
with these stromal cells did not result in increased repopulation
activity recovered at the end of the coculture period (data not
shown).
It has been reported that catecholamines can affect the prolif-
eration and mobilization of HSCs (Katayama et al., 2006; Spiegel
et al., 2007). The fact that we observed an increase in HSCs as
reflected in the number of mice being repopulated with higher
individual donor chimerisms and the fact that this can occur in
explant-cultured AGMs where migration is unlikely to play
a role suggest that the effect catecholamines have on emerging
HSCs and/or their precursors also involves induction of prolifer-
ation or increased production of HSCs from pre-HSCs. Since
HSC expansion in AGM explant cultures has been linked to
increased maturation from pre-HSCs rather than HSC prolifera-
tion (Taoudi et al., 2008), and since we saw a decrease in intra-
aortic clusters and hemogenic endothelial cell numbers in the
absence of catecholamines, the latter possibility is more likely.
It is also unlikely that catecholamines regulate HSC survival
because we saw no increase in apoptosis in AGM HSCs
exposed to a Th inhibitor in culture, and catecholamines were
unable to maintain sorted AGM HSCs in culture in the absence
of stromal support (data not shown).
In addition to its expression in the developing kidney and SNS,
Gata3+ cells were detected in the ventral mesenchyme just
underneath the dorsal aorta. The identity and function of these
subendothelial mesenchymal cells is still highly debated. A
number of known regulators of HSCs are expressed in thisll Stem Cell 11, 554–566, October 5, 2012 ª2012 Elsevier Inc. 561
Figure 5. Catecholamines Can Rescue HSC Activity In Vitro in the Absence of Circulation
(A) Ventral halves of dorsal aortae from E11Gata3+/+ andGata3/ embryos were analyzed forNos3 expression by quantitative RT-PCR. Data is representative of
two independent experiments.
(B) E11.5Gata3+/+ andGata3/ embryo sections were stained for Nos3 (red/Alexa 555) and counterstained with DAPI (blue). Ventral, down; 203/0.45 objective.
(C) Schematic outline of catecholamine treatment of AGMs in explant culture.
(D) Summary of repopulation analysis of recipients injected with cells (1 ee) from Gata3+/+, Gata3+/, and Gata3/ E11/11.5 AGMs that had been exposed to
catecholamine derivatives in explant cultures. See also Figure S3.
(E) Quantitative RT-PCR expression analysis of the a1d- (Adra1d), b2- (Adrb2), and b3- (Adrb3) adrenergic receptors in mesenchymal (MC), endothelial (EC), and
hematopoietic stem cell (HSC) populations sorted from E11.5 aorta-mesenchymes (normalized to Actb and Tbp).
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et al., 1999). It may therefore represent the immediate HSC
microenvironment in the AGM. Whether Gata3 plays an addi-
tional role in AGMhematopoiesis connected with this expression
pattern and whether it interacts with other hematopoietic regula-
tors in this region is currently unknown. The subaortic mesen-
chyme has also been suggested to contain precursors of
HSCs (Bertrand et al., 2005; Rybtsov et al., 2011; Zovein et al.,
2008). Although our data suggest that Gata3 may not be ex-
pressed in AGM-derived HSCs, we cannot rule out that Gata3
is present in some of their precursors, which has been proposed
by other reports (Bertrand et al., 2005; Manaia et al., 2000).
However, the observation that Gata3/ ESCs can contribute
to the myeloid and B lineage in adult mice (Ting et al., 1996)
argues against an essential cell-autonomous role of Gata3 in
the specification of HSCs from their precursors.
We have previously shown that genes coding for regulators of
tissues that develop in the vicinity of the dorsal aorta are upregu-
lated at the time of HSC emergence in the AGM (Mascarenhas
et al., 2009). This led us to hypothesize that the process of
HSC generation occurs in the context of the development of
these other tissues. We have now demonstrated through the
analysis of Gata3- and Th-deficient embryos that there is indeed
a functional link between the developing hematopoietic and
sympathetic nervous system. As with the recently reported role
of blood flow in HSC generation, this highlights that HSC emer-
gence in the AGM does not occur in isolation and has to be
studied in the context of other developmental processes occur-
ring at the same time.EXPERIMENTAL PROCEDURES
Mice and Embryo Generation
Wild-type C57BL/6, Th knockout (Figure S2D and Supplemental Experimental
Procedures), Gata3 knockout (Pandolfi et al., 1995), Gata3 knockout crossed
with Ly-6A GFP transgenic (de Bruijn et al., 2002), and Gata3-LacZ knockin
(van Doorninck et al., 1999) mice were used for timed matings with the day
of vaginal plug detection being considered as day 0. For the pharmacological
rescue experiments, pregnantGata3+/ femaleswere given 100 mg/ml L-phen-
ylephrine (Sigma), 100 mg/ml isoproterenol (Sigma), and 2mg/ml ascorbic acid
(Sigma) in their drinking water starting from day 8.5 after vaginal plug detection
until the day the embryos were obtained. All mice were housed according to
institute regulations and procedures were carried out in compliance with UK
Home Office licenses.
AGM Explant Cultures
E11–11.5 AGMs were cultured on Durapore filters (Millipore) at the air-
liquid interface in M5300 long-term culture medium (Stem Cell Technologies)
supplementedwith 106Mhydrocortisone (Sigma).Where indicated, recombi-
nant murine IL3 (BD Biosciences) at 100 ng/ml or the Th Inhibitor a-Methyl-DL-
tyrosine methyl ester hydrochloride (Sigma) at 5 mM (Wolkersdorfer et al.,
1996) was added to the culture medium. For the in vitro rescue experiments,
10 mM L-phenylephrine (Sigma), 10 mM isoproterenol (Sigma), and 200 mM
ascorbic acid (Sigma) was added to the culture medium and the medium
was refreshed every day. After 2–4 days, AGMswere dissociated with collage-
nase (Sigma) and single-cell suspensions were transplanted into irradiated
recipients or analyzed by flow cytometry.(F) Flow cytometry analysis of the expression of the b2-adrenergic receptor on C
(G–I) Immunohistochemistry on E11.5 wild-type embryo sections with an antibody
in (G). Arrows in (H) and (I) highlight expression on endothelial cells. Ventral, down;
root ganglia; fl, fetal liver; m, myotome; nt, neural tube.
CeLong-Term Transplantations
AGM cell preparations were intravenously injected into recipients that had
received a split dose of 9–9.5 Gy of g irradiation. After 1 and 4 months, donor
contribution to the recipients’ peripheral blood was determined by semiquan-
titative PCR or FACS analysis using antibodies specific to the Ly5.1 or Ly5.2
isoforms. Mice were considered to be repopulated if the donor contribution
was at least 10% by PCR or 5% by FACS.
CFU-S Assays
E10.5 AGM cell preparations were injected at 1 embryo equivalent into irradi-
ated (10 Gy) recipients. Eleven days posttransplantation, the spleens of the
recipients were removed and fixed in Bouin’s solution and the number of
macroscopic colonies per spleen was determined.
Gene Expression Analysis
Tissues and cells were dissociated in Tri Reagent (Sigma), RNA was isolated
and treated with RQ1 DNase I (Promega), and cDNA was prepared using Oligo
dT primers and Superscript II reverse transcriptase (Invitrogen). For the anal-
ysis of different isolated cell populations, an equal number of each cell type
was directly sorted into Tri Reagent. Primers for the quantitative RT-PCR anal-
ysis can be found in the Supplemental Experimental Procedures, and expres-
sion was normalized to b-actin, Actb, and TATA box binding protein, Tbp.
X-gal Staining, Immunohistochemistry, and In Situ Hybridization
Gata3+/lz embryos were stained with X-gal for b-galactosidase as described
previously (Ottersbach and Dzierzak, 2005). Cryosections were then prepared
and counterstained with Neutral Red.
The CD34 immunostaining of Ly-6A GFP+ embryo sections for the quantifi-
cation of GFP+ cells in the endothelial layer was carried out as described previ-
ously (Ling et al., 2004). Using the same protocol, embryo sections were also
stained with the following antibodies: Adrb2 (Abcam), Gata2 (Santa Cruz),
Gata3 (Absea), Nos3 (Abcam), and Th (Millipore). Secondary antibodies
used were anti-rabbit-Alexa 555 (Invitrogen), anti-mouse-Alexa 488 (Invitro-
gen), biotin-conjugated anti-rabbit antibody (Santa Cruz Biotechnology),
biotin-conjugated anti-rat antibody (BD Biosciences), Streptavidin-Cy3 (Strat-
ech Scientific), and Streptavidin-Cy5 (Jackson Immunoresearch). Confocal
images were taken on a Zeiss LSM510METAConfocal Microscope (Carl Zeiss
Ltd., Wellyn, UK).
For in situ hybridization on cryosections, the following riboprobes were
used: Th (Mascarenhas et al., 2009); Gata2: prepared by RT-PCR from E11
AGM cDNA using the following primers; forward, GCACAATGTTAA
CAGGCCAC; reverse, AAGTGGGTCTCTTGGGATGG; Hand1: prepared by
RT-PCR from E11 AGM cDNA using the following primers; forward, TTT
GGACGTCTGAACCCTTC; reverse, CTGTGCGTCTCCTCTCCTTC; and Gfi1:
fragment encompassing nucleotides 2395–2862 (accession number NM
010278). In situ hybridization experiments were performed as described
previously (Ottersbach and Dzierzak, 2005). Bright-field images were
obtained using a Zeiss AxioSkop2 Wide-Field Microscope (Carl Zeiss Ltd.,
Wellyn, UK).
Flow Cytometry Analysis and Cell Sorting
For the detection and analysis of Gata3-expressing cells, collagenase-
dissociated Gata3+/lz AGM cells were loaded with the fluorescent b-galactosi-
dase substrate fluorescein di-b-D-galactopyranoside (FDG,Molecular Probes)
by hypotonic shock and kept on ice for 1 hr before cell sorting experiments or
30 min before further antibody staining for flow cytometry analysis. Wild-type
AGM cells were loaded with FDG alongside for background control. Antibody
staining was performed for 25 min on ice using antibodies specific to CD34,
ckit, CD31, CD41, CD45 (all BD Biosciences), VE-Cadherin (eBioscience),
Adrb2 (Santa Cruz), and anti-rabbit-Alexa 555 (Invitrogen; for the Adrb2
analysis). Dead cells were excluded via 7-aminoactinomycin D staining
(7AAD, Invitrogen).D34+ or CD45+ E11.5 AGM cells.
to the b2-adrenergic receptor (red, Cy3). Nuclear DAPI staining is shown (blue)
objectives were 103/0.25 (G) or 203/0.45 (H and I). ao, dorsal aorta; drg, dorsal
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